After a train carrying chemicals derailed and caught fire in East Palestine, Ohio, in 2023, residents were exposed to ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

Recent advances in genome-editing technologies have unlocked the potential to directly correct pathogenic genetic mutations.

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...

UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, known as ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...

With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing ...

A class of drugs, MDM2 inhibitors, being studied as cancer therapeutics may accidentally damage the protective barriers in the brain and eyes, finds new research in mice.